Global Clinical Trial Outsourcing Market By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4), By Therapeutic Area (Oncology, Hematology, Central Nervous System, Cardiovascular/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, Others), By End User (Biotechnology & Pharmaceutical Companies, Medical Device Companies, Academic & Research Institutions) and By Region, Competition Forecast and Opportunities, 2027
Global clinical trial outsourcing market is anticipated to register robust growth with a significant CAGR in the forecast period, 2023-2027. Clinical trial outsourcing refers to the delegation of several duties involved in conducting clinical trials and related activities by the medical or pharmaceutical companies to indicate what works for the patient and what does not by testing them in a professional setup. The market growth can be attributed to the rising need for new and advanced drugs and therapeutics to be tested and approved to address the rising prevalence of several life-threatening diseases. Moreover, the increasing investments in healthcare research and drug development activities are also adding to the market growth. Outsourcing clinical trials offers several advantages to pharmaceutical and biotech companies such as cost efficiency, minimum timeline, timely result delivery, etc. As a result, pharmaceutical industries are increasingly opting for clinical trial outsourcing services to avail significant advantages in terms of cost as well as efficient drugs or vaccines.
Pharmaceutical companies are looking for ways to reduce overall expenses, for which they need to save costs in the research and development infrastructure and downsize their research staff. Therefore, pharma companies are outsourcing research and development work to a third party in order to increase the success rate, accelerate drug approvals and increase profits. Moreover, growing investments by both private players and government authorities for the development of novel drugs and therapies are providing a boost to the global clinical trial outsourcing market.
In addition, the development of precision medicines is gaining wide traction in the healthcare sector. Precision medicine is a customized healthcare model that has tailored treatments and practices according to a patient’s molecular profiling and genetics. Most of the clinical research outsourcing (CROs) providers are extensively working on developing precision medicine to reduce the overall cost of failure of a drug and develop effective therapy in less time. CROs provide guidance and support through all the stages of precision medicine trials. As a result, several biotech and pharma companies are highly relying on such service providers for drug trials and approvals, which in turn, is adding to the growth of the global clinical trial outsourcing market.
Market Segmentation
The global clinical trial outsourcing market is segmented on the basis of clinical trial phase, therapeutic area, end user, competitive landscape, and regional distribution. On the basis of clinical trial phase, the market is segmented into Phase 0, Phase 1, Phase 3, and Phase 4. Based on the therapeutic area, the market is fragmented into oncology, hematology, central nervous system, cardiovascular/metabolic, respiratory, infectious diseases, immunology, rare diseases, medical devices, and others. By end user, the market is bifurcated between biotechnology & pharmaceutical companies, medical device companies, and academic & research institutions. The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle east and Africa, South America. The United States is anticipated to hold a considerable market share in the coming years due to the presence of large market players in the region.
Company Profile
ICON plc. (PRA Health Sciences), PAREXEL International Corp., Thermo Fischer Scientific, Inc. (Pharmaceutical Product Development, LLC.), Sygnature Discovery Limited, WuXi AppTec Co., Ltd., Laboratory Corporation of America Holdings, Jubilant Biosys Limited, Charles River Laboratories International, Inc., Albany Molecular Research, Inc., and Syneos Health Inc are the leading market players of the global clinical trial outsourcing market.
Report Scope:
In this report, global Clinical Trial outsourcing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Clinical Trial Outsourcing Market, By Clinical Trial Phase:
- Phase 0
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Clinical Trial Outsourcing Market, By Therapeutic Area:
- Oncology
- Hematology
- Central Nervous System
- Cardiovascular/Metabolic
- Respiratory
- Infectious Diseases
- Immunology
- Rare Diseases
- Medical Devices
- Others
- Clinical Trial Outsourcing Market, By End Users:
- Biotechnology & Pharmaceutical Companies
- Medical Device Companies
- Academic & Research Institutions
- Clinical Trial outsourcing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- South America
- Brazil
- Argentina
- Colombia
Company Profiles: Detailed analysis of the major companies present in Global Clinical Trial Outsourcing Market.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
- 1. Product Overview
- 2. Research Methodology
- 3. Executive Summary
- 4. Impact of COVID-19 on Global Clinical Trial Outsourcing Market
- 5. Voice of Customer
- 5.1. Reasons for Clinical Trial Outsourcing
- 5.2. Clinical Trial Outsourcing, By Region
- 5.3. Clinical Trial Outsourcing, By Clinical Trial Phase
- 5.4. Clinical Trial Outsourcing, By Therapeutic Area
- 5.5. Brand Awareness
- 6. Global Clinical Trial Outsourcing Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4)
- 6.2.2. By Therapeutic Area (Oncology, Hematology, Central Nervous System, Cardiovascular/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, Others)
- 6.2.3. By End User (Biotechnology & Pharmaceutical Companies, Medical Device Companies, Academic & Research Institutions)
- 6.2.4. By Company (2021)
- 6.2.5. By Region
- 6.3. Product Market Map
- 7. North America Clinical Trial Outsourcing Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Clinical Trial Phase
- 7.2.2. By Therapeutic Area
- 7.2.3. By End User
- 7.2.4. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Clinical Trial Outsourcing Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Clinical Trial Phase
- 7.3.1.2.2. By Therapeutic Area
- 7.3.1.2.3. By End User
- 7.3.2. Mexico Clinical Trial Outsourcing Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Clinical Trial Phase
- 7.3.2.2.2. By Therapeutic Area
- 7.3.2.2.3. By End User
- 7.3.3. Canada Clinical Trial Outsourcing Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Clinical Trial Phase
- 7.3.3.2.2. By Therapeutic Area
- 7.3.3.2.3. By End User
- 8. Europe Clinical Trial Outsourcing Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Clinical Trial Phase
- 8.2.2. By Therapeutic Area
- 8.2.3. By End User
- 8.2.4. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Clinical Trial Outsourcing Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Clinical Trial Phase
- 8.3.1.2.2. By Therapeutic Area
- 8.3.1.2.3. By End User
- 8.3.2. Germany Clinical Trial Outsourcing Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Clinical Trial Phase
- 8.3.2.2.2. By Therapeutic Area
- 8.3.2.2.3. By End User
- 8.3.3. United Kingdom Clinical Trial Outsourcing Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Clinical Trial Phase
- 8.3.3.2.2. By Therapeutic Area
- 8.3.3.2.3. By End User
- 8.3.4. Italy Clinical Trial Outsourcing Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Clinical Trial Phase
- 8.3.4.2.2. By Therapeutic Area
- 8.3.4.2.3. By End User
- 8.3.5. Spain Clinical Trial Outsourcing Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Clinical Trial Phase
- 8.3.5.2.2. By Therapeutic Area
- 8.3.5.2.3. By End User
- 9. Asia-Pacific Clinical Trial Outsourcing Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Clinical Trial Phase
- 9.2.2. By Therapeutic Area
- 9.2.3. By End User
- 9.2.4. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Clinical Trial Outsourcing Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Clinical Trial Phase
- 9.3.1.2.2. By Therapeutic Area
- 9.3.1.2.3. By End User
- 9.3.2. India Clinical Trial Outsourcing Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Clinical Trial Phase
- 9.3.2.2.2. By Therapeutic Area
- 9.3.2.2.3. By End User
- 9.3.3. South Korea Clinical Trial Outsourcing Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Clinical Trial Phase
- 9.3.3.2.2. By Therapeutic Area
- 9.3.3.2.3. By End User
- 9.3.4. Japan Clinical Trial Outsourcing Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Clinical Trial Phase
- 9.3.4.2.2. By Therapeutic Area
- 9.3.4.2.3. By End User
- 9.3.5. Australia Clinical Trial Outsourcing Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Clinical Trial Phase
- 9.3.5.2.2. By Therapeutic Area
- 9.3.5.2.3. By End User
- 10. South America Clinical Trial Outsourcing Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Clinical Trial Phase
- 10.2.2. By Therapeutic Area
- 10.2.3. By End User
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Clinical Trial Outsourcing Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Clinical Trial Phase
- 10.3.1.2.2. By Therapeutic Area
- 10.3.1.2.3. By End User
- 10.3.2. Argentina Clinical Trial Outsourcing Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Clinical Trial Phase
- 10.3.2.2.2. By Therapeutic Area
- 10.3.2.2.3. By End User
- 10.3.3. Colombia Clinical Trial Outsourcing Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Clinical Trial Phase
- 10.3.3.2.2. By Therapeutic Area
- 10.3.3.2.3. By End User
- 11. Middle East and Africa Clinical Trial Outsourcing Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Clinical Trial Phase
- 11.2.2. By Therapeutic Area
- 11.2.3. By End User
- 11.2.4. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Clinical Trial Outsourcing Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Clinical Trial Phase
- 11.3.1.2.2. By Therapeutic Area
- 11.3.1.2.3. By End User
- 11.3.2. Saudi Arabia Clinical Trial Outsourcing Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Clinical Trial Phase
- 11.3.2.2.2. By Therapeutic Area
- 11.3.2.2.3. By End User
- 11.3.3. UAE Clinical Trial Outsourcing Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Clinical Trial Phase
- 11.3.3.2.2. By Therapeutic Area
- 11.3.3.2.3. By End User
- 12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
- 13. Market Trends & Developments
- 14. Competitive Landscape
- 14.1. ICON plc. (PRA Health Sciences)
- 14.2. PAREXEL International Corp.
- 14.3. Thermo Fischer Scientific, Inc. (Pharmaceutical Product Development, LLC.)
- 14.4. Sygnature Discovery Limited
- 14.5. WuXi AppTec Co., Ltd.
- 14.6. Laboratory Corporation of America Holdings
- 14.7. Jubilant Biosys Limited
- 14.8. Charles River Laboratories International, Inc.
- 14.9. Albany Molecular Research, Inc.
- 14.10. Syneos Health Inc
- 15. Strategic Recommendations
- (Note: The companies list can be customized based on the client requirements.)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook